Curriculum vitae
Degrees 2009-2014 Ph.D. with summa cum laude in Immunology and Translational Medicine, Faculty of Medicine; University of Munich; Germany
DZNE researcher Susanne Wegmann optimizes scientific publishing as an "EMBO Journal Catalyst"
With the support of young group leaders from the scientific community, the EMBO Journal aims to
About Intravacc
Intravacc, located at Utrecht Science Park Bilthoven in the Netherlands, is a leading global contract development and manufacturing organization (CDMO) of innovative vaccines
Research
Our goal to remove hurdles to the development and implementation of innovative interventions extends to the entire translational continuum; etiological biomarkers for age-related
Prof. Stefan Teipel talks about Alzheimer's and Lecanemab in health magazine "Apotheken Umschau"
The newly developed drug Lecanemab - this is the title story of the new issue of the German health
„Donanemab“: Novel Drug Slows Cognitive Decline in Alzheimer’s Disease
In a clinical trial, a novel drug called „Donanemab” has led to a slowing of cognitive decline in people with early
Tau: When a protein paralyzes the flow of information
In Alzheimer's patients, the protein tau gets out of control. Deposits form in the nerve cells, blocking the exchange of information and
At the three DZNE locations Bonn, Rostock/Greifswald and Magdeburg scientists will participate in the so-called “science nights”. They will present their work to the interested public and answer
Bonn, April 6th, 2011. The German Centre for Neurodegenerative Diseases (DZNE) is an attractive address for top scientists from around the world – 53% of the scientific appointments at the DZNE in
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
